A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes
Clinical trial NCT02413398 · COMPLETED
Trial details
- NCT number
- NCT02413398
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-15
- Primary completion
- 2017-11-07
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.